OCM
CRMD icon

Orion Capital Management’s CorMedix CRMD Stock Holding History

Orion Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.6K Sell
3,000
-1,000
-25% -$7.9K 0.01% 353
2026
Q1 		$27.2K Sell
4,000
-1,000
-20% -$7.39K 0.01% 308
2025
Q4 		$58.1K Sell
5,000
-1,000
-17% -$11.1K 0.02% 262
2025
Q3 		$69.8K Buy
+6,000
New +$72.5K 0.02% 240

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Orion Capital Management's CRMD Position: Q2 2026 in Review

Orion Capital Management reduced its CorMedix (CRMD) stake by 25% in Q2 2026, selling an estimated $7.9K and leaving 3,000 shares worth $23.6K. The position accounts for 0.01% of the portfolio, ranked #353.

Orion Capital Management first reported a position in CRMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $69.8K in Q3 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Orion Capital Management held 3,000 shares of CorMedix worth $23.6K as of Q2 2026.
  • Orion Capital Management sold 1,000 CorMedix shares in Q2 2026, an estimated $7.9K.
  • CorMedix made up 0.01% of Orion Capital Management's portfolio in Q2 2026, its #353 holding.
  • Orion Capital Management first reported a position in CorMedix in Q3 2025 and has held it in 4 quarters since.
  • Orion Capital Management's CorMedix position peaked at $69.8K in Q3 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Orion Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.